OSOguz Soylemezoglu

Oguz Soylemezoglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oguz Soylemezoglu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 17 October 2016
      • Vol. 34, 97-100

    Familial Mediterranean fever gene mutation frequencies in a sample Turkish population.

    by Oguz Soylemezoglu, Yasar Kandur, Sevim Gonen, Ali Düzova, Zeynep Birsin Özçakar, Kibriya Fidan, Fatos Yalcinkaya

    Our knowledge about the frequencies of mutations in the Turkish population is based on the studies on the affected patients and hospital-based control groups. We aimed to determine the frequencies of MEFV gene mutations in a population-based field study in Turkey. Turkish citizens aged between 5 and 65 years were included in the study. Cities from seven regions of Turkey were studied. Blood samples were obtained from individuals who gave permission for laboratory experiments, and they were analysed for 10 MEFV gene mutations. Among 500 participants, MEFV mutations were found in 74 (14.8%). Sixty four (12.8%), 7 (1.4%), and 3 (0.6%) participants were heterozygous, compound heterozygous, and homozygous, respectively. Among inhabitants with heterozygous mutations, the most common heterozygous mutations were E148Q/- and M694V/-. Sixteen participants were found to be heterozygous for M694V, 2 were compound heterozygous for M694V/E148Q, and one was homozygous for M694V/M694V mutation; in total, the frequency of M694V allele was 4% (n=20). Twenty-three (4.6%) individuals were heterozygous for common mutations (M694V, M680I, V726A). Total allelic frequency was 8.4%. Our study, which describes the MEFV mutational spectrum and distribution in a healthy Turkish population, found a carrier rate that is much higher than expected.


  • Evaluation of urinary KIM-1, NGAL, and IL-18 levels in determining early renal injury in pediatric cases with hypercalciuria and/or renal calculi

    by Yasar Kandur, Sevim Gonen, Kibriya Fidan, Oguz Soylemezoglu

    One has to measure urinary enzymes and proteins to determine renal dysfunction and tubular injury in earlier stage during the course of disease. The aim of this study was to investigate the role of urinary NGAL (neutrophil gelatinase-associated lipocalin), IL-18 (Interleukin 18), and KIM-1 (kidney injury molecule-1) levels in determining early renal injury in pediatric patients with hypercalciuria (HC) and/or nephrolithiasis (NL) and to compare the levels of these markers between the sick and healthy subjects.


    • 25 May 2015
      • Vol. 33, S152-5

    Familial Mediterranean fever with a single MEFV mutation: comparison of rare and common mutations in a Turkish paediatric cohort.

    by Oguz Soylemezoglu, Yasar Kandur, Ali Duzova, Ozan Ozkaya, Ozgür Kasapcopur, Esra Baskin, Kibriya Fidan, Fatos Yalcinkaya

    Presence of common MEFV gene mutations strengthened the diagnosis of FMF in addition to the typical clinical characteristics of FMF. However, there are also rare mutations. P369S, A744S, R761H, K695R, F479L are the main rare mutations in Turkish population. We aimed to evaluate FMF patients with a single allele MEFV mutation and to compare patients with common and rare mutations. We retrospectively reviewed the medical records of FMF patients with a single allele mutation who were followed up between 2008 and 2013 in six centres. We compared the patients with rare and common mutations for disease severity score, frequent exacerbations ( >1 attack per month), long attack period (>3 day), symptoms, age at the onset of symptoms, gender, consanguinity, and family history. Two hundred and seventeen patients (M/F=101/116) with the diagnosis of FMF and single mutation were included. Heterozygote mutations were defined as common (M694V, V726A, M68OI) and rare mutations (A744S, P369S, K695R, R761H, F479L). Sixty-seven patients (27 males, 40 females) had one single rare mutation and 150 (74 males, 76 females) had one single common mutation. No difference was found between the rare and common mutations with respect to the disease severity score. There was no significant difference between common and rare heterozygote form of mutations in terms of disease severity. Patients with typical characteristics of FMF, with some rare mutations (A744S, P369S) should be treated in the same manner as patients with a common mutation.


    • 15 April 2008
      • Vol. 35  (6) , 1165-8

    HLA-DRB1 alleles and Henoch-Schönlein purpura: susceptibility and severity of disease.

    by Oguz Soylemezoglu, Harun Peru, Sevim Gonen, Aysun Cetinyurek, Necla Buyan

    The genetic basis of susceptibility to Henoch-Schönlein purpura (HSP) may be conferred by a number of gene loci, including the MHC. Associations between human leukocyte antigen (HLA) and disease can help to establish a basis for susceptibility and assist in the prediction of the outcome and clinical heterogeneity. We aimed to investigate the implications of the HLA-DRB1 locus and the susceptibility to HSP, and to determine if there are associations with joint, gastrointestinal, and renal manifestations of the disease. We studied 110 Turkish patients (men/women: 66/44) with HSP. Patients and ethnically matched controls with respect to age and sex (n = 250) were HLA-DRB1 genotyped from DNA determined using molecular based methods. HLA-DRB1 genotype differences between patients with HSP and controls were observed. The frequency of HLA-DRB1 11/14 was higher [odds ratio (OR) 1.97, 95% confidence interval (95% CI) 1.25-3.12, p = 0.003; OR = 1.83, 95% CI = 1.02-3.28, p = 0.035, respectively] and the frequency of HLA-DRB1 10/17 was lower (OR = 1.04, 95% CI = 1.01-1.86, p = 0.035; OR = 3.96, 95% CI = 1.17-13.33, p = 0018, respectively) in patients with HSP compared to controls. No HLA-DRB1 associations with gastrointestinal and renal manifestations were found (p > 0.05). In contrast, HLA-DRB1*11 positivity was increased and HLA-DRB1 14 positivity reduced in HSP patients with joint manifestations (OR = 2.68, 95% CI = 1.09-6.66, p = 0.029; OR = 9.34, 95% CI = 3.38-25.64, p = 0.000, respectively). Also, HLA-DRB1 13 positivity was found to be increased in patients with nephrotic proteinuria (OR = 3.76, 95% CI = 1.25-11.23, p = 0.025). These results suggest that genetic factors from HLA-DRB1 genotypes might be related to the susceptibility to HSP for Turkish children but not to the severity of this disease. Additional studies are required to confirm the association of alleles encoded in the HLA region with the disease progression and severity.


  • Digital calciphylaxis progressing to amputation in a child on continuous ambulatory peritoneal dialysis

    by Sevcan A. Bakkaloglu, Ismail Dursun, Aysenur Kaya, Oguz Soylemezoglu, Enver Hasanoglu, Necla Buyan

    Calciphylaxis is a rare, life-threatening condition of progressive cutaneous necrosis resulting from medial calcification of the small arterioles. It is usually seen in uraemic patients with secondary hyperparathyroidism. An 11-year-old girl with end-stage renal failure and calciphylaxis of the toes is described. She was unresponsive to medical treatment and amputation was required.


  • Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction*

    by Kadriye Reis, Turgay Arinsoy, Ulver Derici, Sevim Gonen, Zerrin Bicik, Oguz Soylemezoglu, Unal Yasavul, Enver Hasanoglu, Sukru Sindel


  • Vitamin D receptor gene polymorphism in hypercalciuric children

    by Necla Buyan, Oğuz Söylemezoğlu, Ozan Özkaya, Sevim Gönen, Müge Mısırlıoğlu, Süleyman Kalman


  • PSEUDOHYPERKALEMIA DUE TO REACTIVE THROMBOCYTOSIS IN AN INFANT WITH YOLK SAC TUMOR

    by Sevcan A. Bakkaloğlu, Oğuz Söylemezoğlu, Ceyda Karadeniz, Aynur Oğuz, Necla Buyan, Enver Hasanoğlu